Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biomagnetic Technologies, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Files registration statement for public offering of 3 mil. units. The San Diego-based manufacturer Of imaging systems estimates that it will sell the units for $5 to $7. Each unit is comprised of one share of common stock, one Class A Warrant and one Class B Warrant. Class A and Class B Warrants will give investors the option to obtain common stock at 125% and 150% of the unit price, respectively, for seven years. The offering is being managed by D. Blech & Company and will be preceded by a one-for-three reverse split of the common stock

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002570

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel